What is CoolStat?
CoolStat operates at the intersection of medical technology and patient-centric care, specializing in advanced temperature management solutions. The company's flagship product, CoolStat, utilizes sophisticated evaporative cooling mechanisms to provide a non-invasive alternative to traditional, often cumbersome, cooling systems. By focusing on portability, ease of use, and patient comfort, the firm addresses critical gaps in clinical settings, particularly for patients suffering from neurogenic fever or those requiring post-cardiac arrest care.
The company's market position is defined by its commitment to replacing invasive cooling methods with safer, more efficient technology. Currently under investigational use, the CoolStat device represents a significant shift in how hospitals manage hyperthermia, offering a scalable solution that integrates seamlessly into existing intensive care workflows. This focus on high-acuity care environments positions the company as a disruptive force in the medical device sector.
How much funding has CoolStat raised?
CoolStat has raised a total of $200K across 1 funding round:
Angel/Seed
$200K
Angel/Seed (2022): $200K with participation from Tedco
Key Investors in CoolStat
Tedco
TEDCO, the Maryland Technology Development Corporation, enhances economic empowerment growth through the fostering of an inclusive entrepreneurial innovation ecosystem. TEDCO identifies, invests in, and helps grow technology and life science-based companies in Maryland.
What's next for CoolStat?
With the recent influx of capital, CoolStat is poised to prioritize the completion of its clinical trials and the expansion of its investigational footprint. The strategic roadmap involves scaling manufacturing capabilities to meet anticipated demand while simultaneously gathering the longitudinal data necessary for full regulatory clearance. Future growth will likely center on establishing partnerships with major hospital networks and expanding the clinical indications for the CoolStat device.
As the company moves toward commercialization, the focus will shift from research and development to market penetration and operational excellence. By leveraging its current financial backing, CoolStat aims to solidify its status as a leader in thermal management, ultimately improving patient outcomes through innovation in non-invasive care. The firm remains committed to its mission of providing safer, more accessible cooling solutions to the global healthcare market.
